Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSCC6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,642
Award facts
- Contract value 100% obligated
- $14,642.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $14,642.04 to DMS Pharmaceutical Group Inc. for the supply of Entyvio 300 mg vials. The award was issued on December 26, 2025, with an ultimate completion date of December 29, 2025, and does not include a set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V contract represents a component of the Defense Logistics Agency's broader $30.3 billion pharmaceutical supply strategy and authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support Department of Defense military healthcare facility operations worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division and maintains an established performance record supplying diverse and specialized pharmaceutical requirements to the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FSCC6?
SPE2DR26FSCC6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26FSCC6 worth?
The government has obligated $14,642 on SPE2DR26FSCC6.
Is contract SPE2DR26FSCC6 an order under another contract?
Yes. SPE2DR26FSCC6 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCC6 competed?
The extent of competition for SPE2DR26FSCC6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award